Amedisys (NASDAQ:AMED – Get Free Report) announced its quarterly earnings data on Wednesday. The health services provider reported $1.00 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19), Briefing.com reports. The firm had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. Amedisys had a net margin of 4.02% and a return on equity of 12.39%. The company’s revenue was up 5.7% on a year-over-year basis. During the same period last year, the business posted $0.98 EPS.
Amedisys Price Performance
Shares of AMED stock traded down $0.85 during trading hours on Thursday, hitting $96.86. The stock had a trading volume of 344,405 shares, compared to its average volume of 337,286. Amedisys has a one year low of $89.55 and a one year high of $98.95. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. The stock’s 50-day moving average price is $96.75 and its two-hundred day moving average price is $95.77. The stock has a market capitalization of $3.17 billion, a price-to-earnings ratio of 34.90, a PEG ratio of 1.87 and a beta of 0.78.
Analysts Set New Price Targets
Several analysts have issued reports on AMED shares. Deutsche Bank Aktiengesellschaft lowered Amedisys from a “buy” rating to a “hold” rating and set a $101.00 target price on the stock. in a research note on Monday, July 29th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $101.00 price objective on shares of Amedisys in a report on Thursday, July 25th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $100.67.
About Amedisys
Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.
See Also
- Five stocks we like better than Amedisys
- What is a Dividend King?
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- Buy P&G Now, Before It Sets A New All-Time High
- Breakout Alert: Qualcomm Just Hit The Rally Button
- What Are Dividend Achievers? An Introduction
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.